Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial

Purpose The detection of lymph-node metastases (N1) with conventional imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for primarily diagnosed prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) PET/CT is successfully introduced for the staging...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2021-02, Vol.48 (2), p.509-520
Hauptverfasser:	Jansen, B. H. E., Bodar, Y. J. L., Zwezerijnen, G. J. C., Meijer, D., van der Voorn, J. P., Nieuwenhuijzen, J. A., Wondergem, M., Roeleveld, T. A., Boellaard, R., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Cancer surgery Cardiology Computed tomography Confidence intervals Diagnostic systems Dissection Fluorine isotopes Imaging Lymph Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Metastases Metastasis Nodes Nomograms Nuclear Medicine Oncology Oncology – Genitourinary Original Original Article Orthopedics Physicians Positron emission Prostate cancer Prostatectomy Radiology Robots Sensitivity Statistical analysis Tomography Tracers Urological surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!